PT Simex Pharmaceutical Indonesia (Indonesia)

Simex Pharmaceutical Indonesia is primarily engaged in drugs acting on the respiratory system activity. Its headquarters is located in Dki Jakarta. The company was founded in 2000. Simex Pharmaceutical Indonesia was founded by a group of visionary entrepreneurs with a mission to improve healthcare outcomes in Indonesia and beyond. The company focuses on the development, manufacturing, and distribution of pharmaceutical products, with a primary emphasis on respiratory system medications. In addition to its primary business line, Simex also engages in the production of over-the-counter medications and health supplements. Simex Pharmaceutical operates several branches across Indonesia, ensuring a strong local presence and accessibility to its products. The company has expanded its operations to include partnerships with international pharmaceutical firms, allowing it to distribute a wider range of products and technologies. Among its main product offerings are inhalers, tablets, and syrups designed to treat various respiratory conditions. Simex Pharmaceutical is known for its commitment to quality and innovation, continuously investing in research and development to enhance its product portfolio. The company is a member of several pharmaceutical associations in Indonesia, which helps it stay abreast of industry trends and regulatory changes. Simex Pharmaceutical also exports its products to several countries in Southeast Asia, contributing to its growing international footprint. With a vision to become a leading pharmaceutical company in the region, Simex Pharmaceutical Indonesia is dedicated to improving patient health through innovative and effective treatments. The company's mission is to provide high-quality, affordable healthcare solutions to meet the needs of patients and healthcare providers alike.